Evidence map›Paper›PMID 36008932›Full record

Observational studyBiomolecules2022

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.

Laure Morimont, Mélanie Dechamps, Clara David, Céline Bouvy, Constant Gillot, Hélène Haguet, Julien Favresse, Lorian Ronvaux, Julie Candiracci, Marielle Herzog and 5 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05593874 (Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections - a Monocentric Prospective Observational Cohort Study), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05593874 completednot on this map

Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections - a Monocentric Prospective Observational Cohort Study

Typeobservational_patient_registrySponsorUniversity Hospital, GenevaRan2022 to 2023Enrolled30ConditionsDiabetic Foot, Chronic Osteomyelitis, Septic ArthritisArmsHistones H3.1 blood levels
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Platelet lipidome alterations in septic shock: a matched case-control study.Research and practice in thrombosis and haemostasis · 2026
    Article
  5. Review
  6. Article
  7. Unraveling NETs in Sepsis: From Cellular Mechanisms to Clinical Relevance.International journal of molecular sciences · 2025
    Review
  8. Review
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Laure MorimontResearch and Development Department, Qualiblood s.a., 5000 Namur, Belgium.ORCID 0000-0001-9195-304X
Mélanie DechampsCardiovascular Intensive Care, Cliniques Universitaires St Luc, 1200 Brussels, Belgium.
Clara DavidResearch and Development Department, Qualiblood s.a., 5000 Namur, Belgium.
Céline BouvyResearch and Development Department, Qualiblood s.a., 5000 Namur, Belgium.
Constant GillotNamur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, Department of Pharmacy, University of Namur, 5000 Namur, Belgium.ORCID 0000-0002-4151-9760
Hélène HaguetNamur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, Department of Pharmacy, University of Namur, 5000 Namur, Belgium.
Julien FavresseNamur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, Department of Pharmacy, University of Namur, 5000 Namur, Belgium.
Lorian RonvauxNamur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, Department of Pharmacy, University of Namur, 5000 Namur, Belgium.
Julie CandiracciBelgian Volition SRL, Parc Scientifique Crealys, 5032 Isnes, Belgium.
Marielle HerzogBelgian Volition SRL, Parc Scientifique Crealys, 5032 Isnes, Belgium.ORCID 0000-0003-1311-101X
Pierre-François LaterreCardiovascular Intensive Care, Cliniques Universitaires St Luc, 1200 Brussels, Belgium.
Julien De PoorterePôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, 1200 Brussels, Belgium.
Sandrine HormanPôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, 1200 Brussels, Belgium.
Christophe BeauloyePôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, 1200 Brussels, Belgium.
Jonathan DouxfilsResearch and Development Department, Qualiblood s.a., 5000 Namur, Belgium.ORCID 0000-0002-7644-5298
University of Namur · BECliniques Universitaires Saint-Luc · BEUCLouvain · BEVolition (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neutrophil extracellular traps’ (NETs’) formation is a mechanism of defense that neutrophils deploy as an alternative to phagocytosis, to constrain the spread of microorganisms. Aim: The aim was to evaluate biomarkers of NETs’ formation in a patient cohort admitted to intensive care unit (ICU) due to infection. Methods: Forty-six septic shock patients, 22 critical COVID-19 patients and 48 matched control subjects were recruited. Intact nucleosomes containing histone 3.1 (Nu.H3.1), or citrullinated histone H3R8 (Nu.Cit-H3R8), free citrullinated histone (Cit-H3), neutrophil elastase (NE) and myeloperoxidase (MPO) were measured. Results: Significant differences in Nu.H3.1 and NE levels were observed between septic shock and critical COVID-19 subjects as well as with controls (p-values < 0.05). The normalization of nucleosome levels according to the neutrophil count improved the discrimination between septic shock and critical COVID-19 patients. The ratio of Nu.Cit-H3R8 to Nu.H3.1 allowed the determination of nucleosome citrullination degree, presumably by PAD4. Conclusions: H3.1 and Cit-H3R8 nucleosomes appear to be interesting markers of global cell death and neutrophil activation when combined. Nu.H3.1 permits the evaluation of disease severity and differs between septic shock and critical COVID-19 patients, reflecting two distinct potential pathological processes in these conditions.

Indexed as

COVID-19Extracellular TrapsShock, SepticBiomarkersHistonesHumansNeutrophilsNucleosomesBiomarkersHistonesNucleosomesCOVID-19NETs’ formationnucleosomesSARS-CoV-2septic shock

Identifiers

PMID36008932
PMCPMC9405965
OpenAlexW4288060537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.